2 Biotech Stocks You Can Buy and Hold for the Next Decade

There are many ways to grow one's wealth over a decade, but few are as accessible as investing in stocks. Even with a relatively modest sum, picking the right investments and letting time and compounding work their magic will generate the kinds of returns most people would be proud to achieve. However, with scores of options to choose from on equity markets, it can sometimes be challenging to know which stocks are worth investing in.

Let's consider two biotech stocks that could generate steady returns in the next 10 years: (NYSE: ABBV) and Axsome Therapeutics (NASDAQ: AXSM).

AbbVie has been a terrific investment over the past decade. Revenue and earnings have generally grown at a good clip, and it has raised its dividend by 288%. Now that its blockbuster medicine Humira has seen its patent expire in the U.S., things are more complicated -- but that's no reason to give up on the company.

Continue reading

Source Fool.com